Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
about
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium ComplexesChemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different MechanismsCellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands.A supramolecular nanovehicle toward systematic, targeted cancer and tumor therapy.Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications.Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor CellsA new class of Ru(II) polyazine agents with potential for photodynamic therapyDual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis.Ultrafast transient IR spectroscopy and DFT calculations of ruthenium(ii) polypyridyl complexesAnticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.A Photoactivatable Platinum(IV) Anticancer Complex Conjugated to the RNA Ligand Guanidinoneomycin.Phototoxicity of strained Ru(ii) complexes: is it the metal complex or the dissociating ligand?Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?Novel BODIPY-based Ru(II) and Ir(III) metalla-rectangles: cellular localization of compounds and their antiproliferative activities.A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy.Cellular Uptake and Photo-Cytotoxicity of a Gadolinium(III)-DOTA-Naphthalimide Complex "Clicked" to a Lipidated Tat Peptide.Ruthenium(ii) complexes with dppz: from molecular photoswitch to biological applications.Ruthenium bistridentate complexes with non-symmetrical hexahydro-pyrimidopyrimidine ligands: a structural and theoretical investigation of their optical and electrochemical properties.d- Versus l-Glucose Conjugation: Mitochondrial Targeting of a Light-Activated Dual-Mode-of-Action Ruthenium-Based Anticancer Prodrug.A Red-Light-Activated Ruthenium-Caged NAMPT Inhibitor Remains Phototoxic in Hypoxic Cancer Cells.Geometry matters: inverse cytotoxic relationship for cis/trans-Ru(ii) polypyridyl complexes from cis/trans-[PtCl2(NH3)2]Theranostic TEMPO-functionalized Ru(ii) complexes as photosensitizers and oxidative stress indicators.Ruthenium complex-modified carbon nanodots for lysosome-targeted one- and two-photon imaging and photodynamic therapy.Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.Photochemical and Photobiological Activity of Ru(II) Homoleptic and Heteroleptic Complexes Containing Methylated Bipyridyl-type Ligands.To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.Taurine-modified Ru(ii)-complex targets cancerous brain cells for photodynamic therapy.Photo-induced cytotoxicity and anti-metastatic activity of ruthenium(ii)-polypyridyl complexes functionalized with tyrosine or tryptophan.Novel Osmium-based Coordination Complexes as Photosensitizers for Panchromatic Photodynamic Therapy.Highly Charged Ruthenium(II) Polypyridyl Complexes as Lysosome-Localized Photosensitizers for Two-Photon Photodynamic Therapy.Spectroscopic Studies on Photoinduced Reactions of the Anticancer Prodrug, trans,trans,trans-[Pt(N3)2(OH)2(py)2].Perspectives of ruthenium(ii) polyazaaromatic photo-oxidizing complexes photoreactive towards tryptophan-containing peptides and derivatives.Molecular photosensitisers for two-photon photodynamic therapy.Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.DFT Investigation of Ligand Photodissociation in [RuII(tpy)(bpy)(py)]2+ and [RuII(tpy)(Me2bpy)(py)]2+ Complexes.Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.Effects of the Bidentate Ligand on the Photophysical Properties, Cellular Uptake, and (Photo)cytotoxicity of Glycoconjugates Based on the [Ru(tpy)(NN)(L)]2+ Scaffold.Homo- and Heteroleptic Phototoxic Dinuclear Metallo-Intercalators Based on RuII (dppn) Intercalating Moieties: Synthesis, Optical, and Biological Studies.New Ruthenium-Based Probes for Selective G-Quadruplex Targeting.Control of the DNA-Binding and Antiproliferative Properties of Hydroxybenzo[b]quinolizinium Derivatives with pH and Light.
P2860
Q26782380-5B3BB13F-A22C-4B31-B12F-BE38CA4F39B4Q28822145-9CA1ADAE-A426-44BE-806B-89E0A15D938CQ33670035-9CECD68B-3E71-416B-ABCA-66BF6711438AQ33893363-5FCEAAC3-C744-449D-AD14-296787445552Q35685706-247528A3-1C79-4728-9585-564FC5ED3986Q36499563-7F859896-7716-45BA-A8AC-E6E263EC4C37Q36761246-C92ADD62-56EE-4A7A-B8AF-02D04EE4BCAEQ37274934-B4599185-8A25-475C-8486-F505179F24C3Q37641185-ECC2AFA4-EA35-4022-80DA-4F42FA68B4A2Q37657724-61102FD8-E662-4CAE-B3CE-6BDB27BDCF8DQ38294800-F2A39891-0CAF-455A-BFE4-923EB039C924Q38696298-6B81104A-5123-4220-9EFE-0E81BF54EA62Q38710506-EDF83250-73F8-474C-BD13-3EEDB37690E8Q38787468-E538DE27-78A8-414A-8782-3A6971F4952CQ38788535-C40F9250-8D34-45E9-B350-6F71144CAC18Q38795345-F1CADAE0-74D0-4C5D-97E1-B383DC5DFC5AQ38899882-59DDC851-E4FB-4FE4-8E7C-FB732D3FFF12Q39582838-E4E91938-BDDB-4639-AEC8-B5BA287DF861Q40777943-D97618C4-240E-4635-AF77-A488428B27C2Q41916219-3002E565-7AF4-427F-8254-4E3844D9BA7DQ42161331-58008FAE-D6C0-4A03-B02D-31066D61A69AQ43483494-237EA245-50C9-49F0-A44A-203A166F3304Q46253060-8CBB8DE5-1BD0-43B2-9C12-99C9C9335B68Q46300143-54DBC3E8-3687-49E6-8B84-4077FE5354A0Q46300487-6A906AD8-76FA-4871-8EFB-80027C0CABBAQ46353606-08EFB081-8915-45DC-9899-EAB9A2FB96B9Q46363596-020A8180-71F4-4DAD-8E76-2A248CF4FC21Q46371577-A06C7069-A127-4461-82AD-C597A781236DQ46391351-14654C94-F03D-44C2-AD24-AF0F02CB660BQ46657843-E6A8D9E3-2D94-4262-9888-42F6DC04B5E4Q47191310-CCD7477B-B6C7-4B6D-BAD9-119D71D4E163Q47303088-F81977E7-F068-4A9B-AF93-739BA3BAA249Q47370653-474B8C19-7B7C-424D-BBA2-58BCB5C55E57Q48044713-443CE3E7-7021-453A-A281-94A4EFAA05B6Q48094567-483491A3-58F8-4042-92D9-DBFAF74ACA8FQ48137591-92852A84-5DC8-4772-BD30-A800E2DD39B7Q48151913-93E8E0DC-8A6A-4F0A-8F15-3D932BF57FDAQ48189128-34192D53-D6F2-4409-8C5B-E9E28D45A79CQ48284269-A263782A-1516-4E25-B84E-7B0B529265CFQ48290499-2BEBEB81-E914-482A-BCF6-8639191D0E99
P2860
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Combination of Ru
@nl
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
@en
type
label
Combination of Ru
@nl
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
@en
prefLabel
Combination of Ru
@nl
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.
@en
P2093
Cristina Mari
Stefano Ferrari
Vanessa Pierroz
P2860
P304
P356
10.1039/C4SC03759F
P577
2015-01-13T00:00:00Z